Perspectives · an exploratory analysis

Described from inside, described from outside

Each pair below puts two write-ups side by side. One draws on an institution working inside the system it describes. The other draws on an institution outside it. In 2 of the 18 pairs the two describe the same specific problem. In the rest they describe the same class of problem, or problems that share a field or a kind of failure. The analysis was done in February 2026, when the collection held 500 problems. It shows where the two views differ in these pairs. It does not show that they always do.

One pair as an example: water contamination treatment. Both write-ups are about the same problem.

Inside: CSIR-NEERI / CSIR-IICT (India)

Binding constraint: Systemic lab-to-field failure across all technologies over 60 years

Root cause: Technologies designed treating field conditions as edge cases

Outside: UC Berkeley / LBNL

Binding constraint: Chemistry-to-field gap for a specific technology

Root cause: Operational complexity in zero-infrastructure settings

18pairs

9kinds of difference

4seen in most pairs

7points compared in each pair

18 pairs

Pair 1Same specific problemhealth

Snakebite Antivenom

Outside source

WHO

Inside institution

Indian institutions / ICMR(India)

Exception

The inside institution (ICMR) is a technical research body, and it frames the problem more narrowly than the outside source (WHO). The kind of institution affects the difference.

7-Dimension Comparison

Binding constraint

Outside

Delivery system: antivenom requires hospitals victims cannot reach

Inside

Product mismatch: antivenom made from wrong regional venoms

Root cause

Outside

Treatment architecture designed for hospitals, not communities

Inside

Regulatory standards that do not require geographic venom representativeness

Key stakeholder

Outside

Community (victims, healers, CHWs)

Inside

Regulators (CDSCO) and manufacturers

Agency of affected pop.

Outside

Active: cultural frameworks, care-seeking decisions, first-response capacity

Inside

Passive: patients who receive (or fail to receive) correct product

Existing capacity visible?

Outside

Visible: traditional healers, community health structures

Inside

Invisible: no mention of community capacity

Solution direction

Outside

New product architecture + community co-designed interventions

Inside

Regulatory mandate for representative venom panels + national venom biobank

Poverty/inequality

Outside

Structural driver: market collapse, poverty spiral

Inside

Context: geographic inequity mentioned but not analyzed as causal

Which differences appear in this pair

↺What holds the problem back

↺Who the key actors are

↺How much say affected people have

·Change people or change the system

·Whose categories are used

✓How precisely the failure is located

·What counts as evidence

·Who controls the data

·An institution criticizing itself

✓Present

◐Partial

↺The other way round

·Not present

Loading…

Described from inside, described from outside